NCT05615935

Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.

Completed NA Results posted Last updated 1 October 2025

What this trial tests

NA trial testing Experiential HIV Testing in Hiv in 74 participants. Completed in 23 February 2023.

Timeline

9 November 2022

Primary endpoint
1 February 2023

23 February 2023

Quick facts

Lead sponsor	National Taiwan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	74
Start date	9 November 2022
Primary completion	1 February 2023
Estimated completion	23 February 2023
Sites	1 location across Taiwan

Drugs / interventions tested

• Experiential HIV Testing

Conditions studied

• Hiv — all drugs for Hiv →
• HIV Testing — all drugs for HIV Testing →

Sponsor

National Taiwan University

Who can join

20 and older, any sex, with Hiv or HIV Testing. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

HIV Testing Related Knowledge and Practice Primary · pre-test(Baseline) and post-test (week 4)

A self-development scale, known as the "HIV Testing-Related Knowledge and Practice Scale," is employed to assess individuals' knowledge and practices pertaining to HIV testing. The scale consists of twenty-eight questions, encompassing both True-False and multiple-choice formats. Participants earn one point for each correct answer, contributing to a total score that ranges from the minimum scores of 0 to the maximum scores of 28. Higher scores signify a more positive outcome, indicating enhanced HIV testing-related knowledge and practice among the participants.

pre-test

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	17.17	± 1.88
Get a Learning Material Only	17.22	± 2.14

post-test

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	19.44	± 2.21
Get a Learning Material Only	17.36	± 2.69

HIV Related Stigma Primary · pre-test (Baseline) and post-test (Week 4)

The Healthcare Provider HIV/AIDS Stigma Scale (HPASS) will be used to assess this outcome. The instrument contains 30 items, each scored on a six-point Likert scale, yielding a minimum total score of 30 and a maximum of 180. Higher scores reflect greater levels of stigma toward people living with HIV, indicating a worse outcome. Validation of the HPASS through factor analysis identified three underlying dimensions. The stereotyping dimension (11 items; score range: 11-66) reflects negative cognitions and beliefs about people living with HIV. The prejudice dimension (13 items; score range: 13-7

(pre-test)HPASS in total

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	89.39	± 16.14
Get a Learning Material Only	86.75	± 22.06

(post-test)HPASS in total

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	85.94	± 20.10
Get a Learning Material Only	88.03	± 20.44

(pre-test)stereotyping

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	36.36	± 6.85
Get a Learning Material Only	38.36	± 8.43

(post-test)stereotyping

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	36.31	± 7.66
Get a Learning Material Only	38.03	± 9.20

(pre-test)prejudice

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	35.78	± 8.51
Get a Learning Material Only	34.44	± 12.11

(post-test)prejudice

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	33.14	± 10.73
Get a Learning Material Only	34.72	± 10.31

(pre-test)discrimination

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	17.25	± 5.61
Get a Learning Material Only	13.94	± 5.68

(post-test)discrimination

Group	Value	95% CI
Get a Learning Material and a Experiential HIV Testing	16.50	± 5.59
Get a Learning Material Only	15.28	± 5.32

Sponsor's own description

This is a randomized controlled trial design. The investigators plan to recruit about 60 to 70 emergency department nurses from a medical center in Taipei, Taiwan. After completing the paper consent form, these nurses will be randomly assigned to 2 groups, which are a control group and an experimental group. The pre-test includes the demographic data sheet, HIV testing related knowledge and practice scale, and The Health Care Provider HIV/ AIDS Stigma Scale (HPASS). All nurses will receive a learning material when they finish the pre-test. In addition, the experimental group will be provided a real HIV testing and counselling by a researcher. The post-test will be finished one month later of pre-test in the control group, and one month later while the intervention completed in the experimental group. The semi-structural interview will be performed to the experimental group to collect and analyze their opinion toward the experiential HIV testing.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Enhancing HIV knowledge and reducing stigma among emergency nurses through experiential self-testing: A mixed-methods study.
   He CR, Chang JC, Liu CY, Yang BJ, et al · · 2026 · PMID 41455361 · DOI 10.1016/j.nepr.2025.104694